Literature DB >> 20603256

Understanding variation in vitamin A supplementation among NICUs.

Heather C Kaplan1, Meredith E Tabangin, Diana McClendon, Jareen Meinzen-Derr, Peter A Margolis, Edward F Donovan.   

Abstract

OBJECTIVE: We examined and characterized variation among NICUs in the use of vitamin A supplementation for the prevention of bronchopulmonary dysplasia in extremely low birth weight infants.
METHODS: An historical cohort study of extremely low birth weight infants admitted within 7 days after birth to NICUs participating in the Pediatric Health Information System database, between January 1, 2005, and March 31, 2008, was performed. NICU medical directors were surveyed to determine attitudes and decision-making regarding adoption of vitamin A supplementation. The proportion of infants receiving vitamin A at each center was measured over time. Patient and hospital characteristics associated with vitamin A use were examined.
RESULTS: Among 4184 eligible infants cared for in 30 NICUs, 1005 infants (24%) received vitamin A. Eighteen centers (60%) used vitamin A for some patients. Infants discharged in 2007 (odds ratio: 2.7 [95% confidence interval: 1.4-5.3]) and 2008 (odds ratio: 2.8 [95% confidence interval: 1.4-5.8]), compared with 2005, were more likely to receive vitamin A. NICU medical directors from centers using vitamin A, compared with centers that did not adopt vitamin A supplementation, reported stronger beliefs in the efficacy of vitamin A to reduce the incidence of bronchopulmonary dysplasia (83% vs 33%; P = .03) and in the ease with which vitamin A could be implemented (75% vs 22%; P = .02).
CONCLUSIONS: Although the use of vitamin A is increasing, marked variation across NICUs remains. Provider attitudes and system characteristics seem to influence vitamin A adoption.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20603256     DOI: 10.1542/peds.2009-3085

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  Up-date on the NeoVitaA Trial: Obstacles, challenges, perspectives, and local experiences.

Authors:  Sascha Meyer; Ludwig Gortner
Journal:  Wien Med Wochenschr       Date:  2016-09-26

2.  Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.

Authors:  Monika M Gadhia; Gary R Cutter; Steven H Abman; John P Kinsella
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

3.  Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011.

Authors:  S W Patrick; H C Kaplan; M Passarella; M M Davis; S A Lorch
Journal:  J Perinatol       Date:  2014-06-12       Impact factor: 2.521

4.  Hospital variation in nitric oxide use for premature infants.

Authors:  Michael R Stenger; Jonathan L Slaughter; Kelly Kelleher; Edward G Shepherd; Mark A Klebanoff; Patricia Reagan; Leif D Nelin; William Gardner
Journal:  Pediatrics       Date:  2012-03-12       Impact factor: 7.124

5.  Vitamin A supplementation in extremely low-birth-weight infants: subgroup analysis in small-for-gestational-age infants.

Authors:  Vedang A Londhe; Tracy L Nolen; Abhik Das; Rosemary D Higgins; Jon E Tyson; William Oh; Sherin U Devaskar
Journal:  Am J Perinatol       Date:  2013-01-17       Impact factor: 1.862

Review 6.  Predictors of bronchopulmonary dysplasia.

Authors:  Andrea Trembath; Matthew M Laughon
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

7.  Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial.

Authors:  Matthew A Rysavy; Lei Li; Jon E Tyson; Erik A Jensen; Abhik Das; Namasivayam Ambalavanan; Matthew M Laughon; Rachel G Greenberg; Ravi M Patel; Claudia Pedroza; Edward F Bell
Journal:  J Pediatr       Date:  2021-05-15       Impact factor: 6.314

Review 8.  The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.

Authors:  Jennifer J P Collins; Dick Tibboel; Ismé M de Kleer; Irwin K M Reiss; Robbert J Rottier
Journal:  Front Med (Lausanne)       Date:  2017-05-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.